Touyun Biotech Group Limited
1332.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$434.87M
Close$
Share Statistics
| Market cap | $434.87 Million |
|---|---|
| Enterprise Value | $919.06 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -0.6 |
| Outstanding Shares | 2,805,952,000 |
Return
| Return on Equity | 130.68% |
|---|---|
| Return on Assets | 18.88% |
| Return on Invested Capital | -27.98% |
Valuation & Multiples
| P/E Ratio | 2.28 |
|---|---|
| PEG | 0.14 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.89 |
| Enterprise Value to EBIT | -9.75 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.53 |
| Debt to Equity | 3.46 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Touyun Biotech Group Limited
302 employees
CEO: Liang Wang Touyun Biotech Group Limited functions as a diversified investment holding company, primarily focused on the global design, development, manufacturing, and sale of a wide array of packaging products. Its market presence extends across Ho...